Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/49103| Title: | Point-of-care CYP2C19 genotyping in patients prescribed clopidogrel therapy following a percutaneous coronary intervention |
| Authors: | Wirth, Francesca Xuereb, Robert G. Fenech, Albert Azzopardi, Lilian M. |
| Authors: | Wirth, Francesca Xuereb, Robert G. Fenech, Albert Azzopardi, Lilian M. |
| Keywords: | Clopidogrel Coronary heart disease -- Chemotherapy -- Malta Pharmacogenetics -- Malta Coronary arteries -- Stenosis -- Prevention Point-of-care testing -- Evaluation |
| Issue Date: | 2015-10 |
| Publisher: | American College of Clinical Pharmacy |
| Citation: | Wirth, F., Xuereb, R. G., Fenech, A., & Azzopardi, L. M. (2015, October). Point-of-care CYP2C19 genotyping in patients prescribed clopidogrel therapy following a percutaneous coronary intervention. American College of Clinical Pharmacy (ACCP) Conference, San Francisco, California, USA. e75. |
| Abstract: | A poster presentation regarding point-of-care CYP2C19 genotyping in patients prescribed clopidogrel therapy following a percutaneous coronary intervention |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/49103 |
| Appears in Collections: | Scholarly Works - FacM&SPha |
Files in This Item:
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.